Pharmacological modulation of dietary lipid-induced cerebral capillary dysfunction: Considerations for reducing risk for Alzheimer’s disease

QR Code

Pharmacological modulation of dietary lipid-induced cerebral capillary dysfunction: Considerations for reducing risk for Alzheimer’s disease

An increasing body of evidence suggests that cerebrovascular dysfunction and microvessel disease precede the evolution of hallmark pathological features that characterise Alzheimer’s disease (AD), consistent with a causal association for onset or progression. Recent studies, principally in genetical...

Full description

Bibliographic Details
Main Authors:	Pallebage-Gamarallage, M., Takechi, Ryusuke, Lam, Virginie, Elahy, Mina, Mamo, John
Format:	Journal Article
Published:	2015
Online Access:	http://hdl.handle.net/20.500.11937/40843

Similar Items

Long-term probucol therapy continues to suppress markers of neurovascular inflammation in a dietary induced model of cerebral capillary dysfunction
by: Takechi, Ryu, et al.
Published: (2014)

Restoration of dietary-fat induced blood-brain barrier dysfunction by anti-inflammatory lipid-modulating agents
by: Pallebage-Gamarallage, Menuka, et al.
Published: (2012)

Nutritional and pharmacological regulation of cerebral capillary function
by: Pallebage-Gamarallage, Menuka Madhavi Somapala
Published: (2012)

Colocalisation of plasma derived apo B lipoproteins with cerebral proteoglycans in a transgenic-amyloid model of Alzheimer's disease
by: Lam, Virginie, et al.
Published: (2011)

Aging-Related Changes in Blood-Brain Barrier Integrity and the Effect of Dietary Fat
by: Takechi, Ryusuke, et al.
Published: (2012)

The vitamin D, ionised calcium and parathyroid hormone axis of cerebral capillary function: Therapeutic considerations for vascular-based neurodegenerative disorders
by: Lam, V., et al.
Published: (2015)

Nutraceutical agents with anti-inflammatory properties prevent dietary saturated-fat induced disturbances in blood-brain barrier function in wild-type mice
by: Takechi, Ryusuke, et al.
Published: (2013)

Post-prandial lipid metabolism, lipid-modulating agents and cerebrovascular integrity: Implications for dementia risk
by: Pallebage-Gamarallage, Menuka, et al.
Published: (2010)

Dietary fats, cerebrovasculature integrity and Alzheimer's disease risk
by: Takechi, Ryu, et al.
Published: (2010)

A Diet Enriched in Docosahexanoic Acid Exacerbates Brain Parenchymal Extravasation of Apo B Lipoproteins Induced by Chronic Ingestion of Saturated Fats
by: Pallebage-Gamarallage, Menuka, et al.
Published: (2012)

Probucol prevents blood-brain barrier dysfunction in wild-type mice induced by saturated fat or cholesterol feeding
by: Takechi, Ryu, et al.
Published: (2013)

The Effect of Atorvastatin, Pravastatin and Ibuprofen on Dietary-Fat Induced Disturbances in Blood-Brain Barrier Function
by: Pallebage-Gamarallage, Menuka, et al.
Published: (2010)

The effect of exogenous cholesterol and lipid modulating agents on apolipoprotein B and amyloid-beta abundance in the absorptive epithelial cells of the small intestine
by: Pallebage-Gamarallage, Menuka, et al.
Published: (2008)

Effect of fatty acids on enterocytic beta-amyloid abundance: Possible aetiology in Alzheimer’s disease
by: Galloway, S., et al.
Published: (2008)

An investigation of a vitamin D, ionised calcium and parathyroid hormone regulatory axis of cerebral capillary function: Implications for cognitive performance in ageing
by: Lam, Virginie
Published: (2015)

Peripheral metabolism of lipoprotein-amyloid beta as a risk factor for Alzheimer's disease: potential interactive effects of APOE genotype with dietary fats
by: D'Alonzo, Zachary, et al.
Published: (2023)

Nicotine Attenuates Disruption of Blood-Brain Barrier Induced by Saturated-Fat Feeding in Wild-Type Mice.
by: Elahy, M., et al.
Published: (2015)

Probucol Suppresses Enterocytic Accumulation of Amyloid-β Induced by Saturated Fat and Cholesterol Feeding
by: Pallebage-Gamarallage, Menuka, et al.
Published: (2011)

Blood-brain barrier dysfunction developed during normal aging is associated with inflammation and loss of tight junctions but not with leukocyte recruitment
by: Elahy, Mina, et al.
Published: (2015)

Anti-hypertensive agents do not prevent blood-brain barrier dysfunction and cognitive deficits in dietary-induced obese mice
by: Mamo, John, et al.
Published: (2017)

Disruption of blood-brain barrier function by chronic intake of saturated fat and cholesterol : implications for Alzheimer’s disease risk
by: Takechi, Ryusuke
Published: (2010)

The differential effects of fatty acids on enterocytic abundance of amyloid-beta
by: Galloway, Susan, et al.
Published: (2019)

Attenuation of chronic tension headache frequency and severity with daily l-arginine and aged garlic extract dietary supplementation
by: Chaliha, Devahuti, et al.
Published: (2021)

Synergistic effects of high fat feeding and apolipoprotein E deletion on enterocytic amyloid-beta abundance.
by: Galloway, Susan, et al.
Published: (2008)

Long-Term Supplementation of Microencapsulated ursodeoxycholic Acid Prevents Hypertension in a Mouse Model of Insulin Resistance:
by: Al-Salami, Hani, et al.
Published: (2016)

Differential effects of saturated fatty acid, monounsaturated fatty acid and polyunsaturated fatty acid on chylomicron metabolism in the small intestine
by: Galloway, S., et al.
Published: (2008)

Chylomicron amyloi-beta in the aetiology of Alzheimer's disease
by: Takechi, Ryu, et al.
Published: (2008)

Probucol prevents blood–brain barrier dysfunction and cognitive decline in mice maintained on pro-diabetic diet
by: Mamo, John, et al.
Published: (2018)

PHARMACOLOGICAL EVALUATION OF NOVEL COMPOUNDS AS ALZHEIMER’S DISEASE TREATMENT
by: Li, Tian-Tian
Published: (2024)

Differential effects of dietary fatty acids on the cerebral distribution of plasma-derived apo B lipoproteins with amyloid-beta
by: Takechi, Ryu, et al.
Published: (2010)

Probucol Reduces Enterocytic Amyloid-beta Relative to Chylomicron Apolipoprotein B in Mice Chronically Fed Saturated Fats
by: Takechi, Ryu, et al.
Published: (2010)

Chemicals used for the induction of Alzheimers disease-like cognitive dysfunctions in rodents
by: Mahdi, Onesimus, et al.
Published: (2019)

The Serum Concentration of the Calcium Binding Protein S100B is Positively Associated with Cognitive Performance in Older Adults
by: Lam, Virginie, et al.
Published: (2013)

Reduced awareness of executive dysfunction in Alzheimer's disease is associated with increased carer burden
by: Booney, K., et al.
Published: (2007)

Blood-brain barrier dysfunction precedes cognitive decline and neurodegeneration in diabetic insulin resistant mouse model: An implication for causal link
by: Takechi, Ryu, et al.
Published: (2017)

The chronic cerebral hypoperfusion model induces proinflammatory cascades in Alzheimer's disease
by: Abedi, Zahra, et al.
Published: (2024)

Bio-Spectroscopic Imaging Provides Evidence of Hippocampal Zn Deficiency and Decreased Lipid Unsaturation in an Accelerated Ageing Mouse Model
by: Fimognari, Nicholas, et al.
Published: (2018)

Antioxidants and dementia risk: Consideration through a cerebrovascular perspective
by: Lam, V., et al.
Published: (2016)

Contemporary lipidomic analytics: opportunities and pitfalls
by: Giles, C., et al.
Published: (2018)

Ageing and Mesothelioma Drive Lipid Accumulation and Dysfunction in Dendritic Cells and Macrophages
by: Sheeraz, Mohd
Published: (2022)